Search
ANI Pharmaceuticals Inc
ANIPAdd to Watchlist
72.000USD
-1.160-1.59%
Close 10-30 16:00（ET）
1.65BMarket Cap
17.51P/E TTM
ANI Pharmaceuticals Inc (ANIP) Stock Price Target & Forecast
Analyst Rating
Based on 9 analysts giving stock ratings to ANI Pharmaceuticals Inc in the past month.
Buy
3 Strong Buy
4 Buy
2 Hold
0 Sell
0 Strong Sell
Target Price
104.625USD+45.90%
ANIP Analyst Recommendation Trends
In the current month, ANIP has received 4 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. ANIP average Analyst price target in the last month is 104.625.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
2
2
1
0
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9
9
8
7
8
8
8
8
ANIP Analyst Rating for Peer Comparison
Updated: Oct 29, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
8
16
12
1
0
37
Amgen Inc
AMGN
4
9
19
3
1
36
Eli Lilly and Co
LLY
10
19
3
1
0
33
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
AbbVie Inc
ABBV
8
18
6
0
0
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Merck & Co Inc
MRK
7
16
8
0
0
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Bristol-Myers Squibb Co
BMY
5
6
18
1
0
30
Financial Forecasting
Based on analysts' estimates, ANIP EPS is projected to reach 2.181 in FY2026Q3, following reported EPS of 1.087 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
2.00
1.30
2.05
2.18
2.82
Actual
1.23
1.31
1.09
--
--
Surprise
-38.51%
+0.52%
-46.98%
--
--
FAQs
What is ANI Pharmaceuticals Inc's expected revenue for the next quarter?
ANI Pharmaceuticals Inc's expected revenue is 280.20M.
What is ANI Pharmaceuticals Inc's price target?
Analysts forecast that ANI Pharmaceuticals Inc's price target is USD 104.62, with the highest forecast at USD 121.00 and the lowest forecast at USD 85.00.
How have ANI Pharmaceuticals IncANIP's recent earnings per share performed?
The market expectation was USD 1.09, while ANI Pharmaceuticals IncANIP's earnings per share (EPS) for the previous quarter was USD 1.31. EPS for the next quarter is expected at USD 2.18.
What is the analyst rating for ANI Pharmaceuticals Inc?
Based on the ratings of ANI Pharmaceuticals Inc's stock from 9 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.